Literature DB >> 1709696

Chimeric polioviruses that include sequences derived from two independent antigenic sites of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies against FMDV in guinea pigs.

J D Kitson1, K L Burke, L A Pullen, G J Belsham, J W Almond.   

Abstract

Five poliovirus recombinants containing sequences corresponding to foot-and-mouth disease virus (FMDV) antigenic sites were constructed. Viable virus was recovered from four of these plasmids, in which the VP1 beta B-beta C loop (antigenic site 1) of poliovirus type 1 Sabin had been replaced with sequences derived from the VP1 beta G-beta H loop (antigenic site 1) of FMDV O1 Kaufbeuren (O1K), chimera O1.1 (residues 141 to 154), chimera O1.2 (residues 147 to 156), and chimera O1.3 (residues 140 to 160) or from the beta B-beta C loop of VP1 (antigenic site 3) in chimera O3.1 (residues 40 to 49). One chimera (O1.3) was neutralized by FMDV-specific polyclonal serum and monoclonal antibodies directed against antigenic site 1 of FMDV. Chimeras O1.3 and O3.1 induced site-specific FMDV-neutralizing antibodies in guinea pigs. Chimera O1.3 was capable of inducing a protective response against FMDV challenge in some guinea pigs.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1709696      PMCID: PMC240962     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Neutralization sites of type O1 foot-and-mouth disease virus defined by monoclonal antibodies and neutralization-escape virus variants.

Authors:  J W Stave; J L Card; D O Morgan; V N Vakharia
Journal:  Virology       Date:  1988-01       Impact factor: 3.616

2.  The complete nucleotide sequence of a bovine enterovirus.

Authors:  J A Earle; R A Skuce; C S Fleming; E M Hoey; S J Martin
Journal:  J Gen Virol       Date:  1988-02       Impact factor: 3.891

3.  Structure of a human common cold virus and functional relationship to other picornaviruses.

Authors:  M G Rossmann; E Arnold; J W Erickson; E A Frankenberger; J P Griffith; H J Hecht; J E Johnson; G Kamer; M Luo; A G Mosser
Journal:  Nature       Date:  1985 Sep 12-18       Impact factor: 49.962

4.  Synthesis of infectious poliovirus RNA by purified T7 RNA polymerase.

Authors:  S van der Werf; J Bradley; E Wimmer; F W Studier; J J Dunn
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

5.  Antigen chimaeras of poliovirus as potential new vaccines.

Authors:  K L Burke; G Dunn; M Ferguson; P D Minor; J W Almond
Journal:  Nature       Date:  1988-03-03       Impact factor: 49.962

6.  Conservation in vivo of protease cleavage sites in antigenic sites of poliovirus.

Authors:  P D Minor; M Ferguson; A Phillips; D I Magrath; A Huovilainen; T Hovi
Journal:  J Gen Virol       Date:  1987-07       Impact factor: 3.891

7.  Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virus.

Authors:  N Parry; G Fox; D Rowlands; F Brown; E Fry; R Acharya; D Logan; D Stuart
Journal:  Nature       Date:  1990-10-11       Impact factor: 49.962

8.  The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid).

Authors:  G Fox; N R Parry; P V Barnett; B McGinn; D J Rowlands; F Brown
Journal:  J Gen Virol       Date:  1989-03       Impact factor: 3.891

9.  Analysis of neutralizing epitopes on foot-and-mouth disease virus.

Authors:  E Pfaff; H J Thiel; E Beck; K Strohmaier; H Schaller
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

10.  Poliovirus type 1/type 3 antigenic hybrid virus constructed in vitro elicits type 1 and type 3 neutralizing antibodies in rabbits and monkeys.

Authors:  M G Murray; R J Kuhn; M Arita; N Kawamura; A Nomoto; E Wimmer
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

View more
  13 in total

Review 1.  Foot-and-mouth disease.

Authors:  Marvin J Grubman; Barry Baxt
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

2.  Attenuated poliovirus strain as a live vector: expression of regions of rotavirus outer capsid protein VP7 by using recombinant Sabin 3 viruses.

Authors:  N M Mattion; P A Reilly; S J DiMichele; J C Crowley; C Weeks-Levy
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

3.  Use of random systematic mutagenesis to generate viable human rhinovirus 14 chimeras displaying human immunodeficiency virus type 1 V3 loop sequences.

Authors:  A D Smith; D A Resnick; A Zhang; S C Geisler; E Arnold; G F Arnold
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

4.  Immunogenicity of an aphthovirus chimera of the glycoprotein of vesicular stomatitis virus.

Authors:  P R Grigera; M Garcia-Briones; O Periolo; J L la Torre; R R Wagner
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

5.  Release of virus-like particles from cells infected with poliovirus replicons which express human immunodeficiency virus type 1 Gag.

Authors:  D C Porter; L R Melsen; R W Compans; C D Morrow
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

6.  Poliovirus chimeras expressing sequences from the principal neutralization domain of human immunodeficiency virus type 1.

Authors:  J F Dedieu; J Ronco; S van der Werf; J M Hogle; Y Henin; M Girard
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

7.  Complementation of a poliovirus defective genome by a recombinant vaccinia virus which provides poliovirus P1 capsid precursor in trans.

Authors:  D C Ansardi; D C Porter; C D Morrow
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

8.  Encapsidation of genetically engineered poliovirus minireplicons which express human immunodeficiency virus type 1 Gag and Pol proteins upon infection.

Authors:  D C Porter; D C Ansardi; W S Choi; C D Morrow
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

9.  Vaccines prepared from chimeras of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies and protective immunity to multiple serotypes of FMDV.

Authors:  E Rieder; B Baxt; J Lubroth; P W Mason
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

10.  Identification of H-2d restricted T cell epitope of foot-and-mouth disease virus structural protein VP1.

Authors:  Xin-Sheng Liu; Yong-Lu Wang; Yong-Guang Zhang; Yu-Zhen Fang; Li Pan; Jian-Liang Lu; Peng Zhou; Zhong-Wang Zhang; Shou-Tian Jiang
Journal:  Virol J       Date:  2011-09-07       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.